Literature DB >> 25156829

Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein.

Eun-Jin Bae1, Na-Young Yang1, Miyoung Song1, Cheol Soon Lee2, Jun Sung Lee1, Byung Chul Jung3, He-Jin Lee2, Seokjoong Kim4, Eliezer Masliah5, Sergio Pablo Sardi6, Seung-Jae Lee7.   

Abstract

Deposition of α-synuclein aggregates occurs widely in the central and peripheral nervous systems in Parkinson's disease (PD). Although recent evidence has suggested that cell-to-cell transmission of α-synuclein aggregates is associated with the progression of PD, the mechanism by which α-synuclein aggregates spread remains undefined. Here, we show that α-synuclein aggregates are transmitted from cell to cell through a cycle involving uptake of external aggregates, co-aggregation with endogenous α-synuclein and exocytosis of the co-aggregates. Moreover, we find that glucocerebrosidase depletion, which has previously been strongly associated with PD and increased cognitive impairment, promotes propagation of α-synuclein aggregates. These studies define how α-synuclein aggregates spread among neuronal cells and may provide an explanation for how glucocerebrosidase mutations increase the risk of developing PD and other synucleinopathies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156829      PMCID: PMC4452288          DOI: 10.1038/ncomms5755

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  34 in total

1.  Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells.

Authors:  He-Jin Lee; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2002-09-25       Impact factor: 5.157

2.  Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions.

Authors:  Ara Jang; He-Jin Lee; Ji-Eun Suk; Jin-Woo Jung; Kwang-Pyo Kim; Seung-Jae Lee
Journal:  J Neurochem       Date:  2010-03-24       Impact factor: 5.372

3.  Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

Authors:  He-Jin Lee; Ji-Eun Suk; Eun-Jin Bae; Jung-Ho Lee; Seung R Paik; Seung-Jae Lee
Journal:  Int J Biochem Cell Biol       Date:  2008-01-20       Impact factor: 5.085

4.  CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.

Authors:  S Pablo Sardi; Jennifer Clarke; Cathrine Kinnecom; Thomas J Tamsett; Lingyun Li; Lisa M Stanek; Marco A Passini; Gregory A Grabowski; Michael G Schlossmacher; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 5.  Zooming into protein oligomerization in neurodegeneration using BiFC.

Authors:  Susana A Gonçalves; Joana E Matos; Tiago F Outeiro
Journal:  Trends Biochem Sci       Date:  2010-06-17       Impact factor: 13.807

6.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

Authors:  Sheila M Fleming; Jonathan Salcedo; Pierre-Olivier Fernagut; Edward Rockenstein; Eliezer Masliah; Michael S Levine; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

7.  Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-07-05       Impact factor: 17.088

8.  Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Authors:  Edward Rockenstein; Margaret Mallory; Makoto Hashimoto; David Song; Clifford W Shults; Ingrid Lang; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

9.  Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.

Authors:  Elodie Angot; Jennifer A Steiner; Carla M Lema Tomé; Peter Ekström; Bengt Mattsson; Anders Björklund; Patrik Brundin
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

10.  Formation of toxic oligomeric alpha-synuclein species in living cells.

Authors:  Tiago Fleming Outeiro; Preeti Putcha; Julie E Tetzlaff; Robert Spoelgen; Mirjam Koker; Filipe Carvalho; Bradley T Hyman; Pamela J McLean
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more
  77 in total

1.  Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.

Authors:  Changyoun Kim; Edward Rockenstein; Brian Spencer; Hyung-Koo Kim; Anthony Adame; Margarita Trejo; Klodjan Stafa; He-Jin Lee; Seung-Jae Lee; Eliezer Masliah
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

Review 2.  Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Authors:  Trevor Tyson; Jennifer A Steiner; Patrik Brundin
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

Review 3.  GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.

Authors:  Parker H Johnson; Neal J Weinreb; James C Cloyd; Paul J Tuite; Reena V Kartha
Journal:  Mol Genet Metab       Date:  2019-10-23       Impact factor: 4.797

Review 4.  Deregulation of autophagy and vesicle trafficking in Parkinson's disease.

Authors:  Patricia Sheehan; Zhenyu Yue
Journal:  Neurosci Lett       Date:  2018-04-05       Impact factor: 3.046

Review 5.  Defects in trafficking bridge Parkinson's disease pathology and genetics.

Authors:  Asa Abeliovich; Aaron D Gitler
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

6.  Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy.

Authors:  Omar El-Agnaf; Cassia Overk; Edward Rockenstein; Michael Mante; Jazmin Florio; Anthony Adame; Nishant Vaikath; Nour Majbour; Seung-Jae Lee; Changyoun Kim; Eliezer Masliah; Robert A Rissman
Journal:  Neurobiol Dis       Date:  2017-05-02       Impact factor: 5.996

Review 7.  N-terminal fusion potentiates α-synuclein secretion [correction].

Authors:  Björn H Falkenburger
Journal:  Cell Mol Neurobiol       Date:  2018-10-04       Impact factor: 5.046

8.  Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function.

Authors:  Dong-Kyu Kim; Hee-Sun Lim; Ichiro Kawasaki; Yhong-Hee Shim; Nishant N Vaikath; Omar M A El-Agnaf; He-Jin Lee; Seung-Jae Lee
Journal:  Autophagy       Date:  2016-08-02       Impact factor: 16.016

9.  α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes.

Authors:  Aysegul Dilsizoglu Senol; Maura Samarani; Sylvie Syan; Carlos M Guardia; Takashi Nonaka; Nalan Liv; Patricia Latour-Lambert; Masato Hasegawa; Judith Klumperman; Juan S Bonifacino; Chiara Zurzolo
Journal:  PLoS Biol       Date:  2021-07-20       Impact factor: 8.029

Review 10.  Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease.

Authors:  Caleb Pitcairn; Willayat Yousuf Wani; Joseph R Mazzulli
Journal:  Neurobiol Dis       Date:  2018-03-14       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.